The DD-ACE genotype and cardiovascular disease

Area of Science:

• Cardiovascular Genetics
• Molecular Cardiology
• Genomics

Background:

• The renin-angiotensin-aldosterone system (RAS) is crucial for cardiovascular regulation.
• Therapeutic agents targeting RAS significantly impact heart failure and myocardial infarction (MI).
• Genetic variations in RAS genes, like the angiotensin converting enzyme (ACE), may influence cardiovascular disease (CVD) risk.

Purpose of the Study:

• To review the evidence linking ACE gene polymorphisms, specifically the DD-ACE polymorphism, with cardiovascular diseases.
• To evaluate the association between the DD-ACE genotype and phenotypic expression of cardiovascular conditions such as MI and ischemic heart disease.

Main Methods:

• Literature search of the Medline database (1990-2000) using keywords: myocardial infarction, ischemic heart disease, angiotensin converting enzyme, polymorphisms.
• Inclusion of relevant clinical studies on cardiovascular disease related to ACE genotype.
• Analysis of reference citations from relevant articles.

Main Results:

• Several small studies suggest an association between the DD-ACE polymorphism and manifestations of ischemic heart disease or other cardiac endpoints.
• A large prospective study found no significant risk associated with the ACE gene.
• Evidence indicates the DD-ACE genotype may adversely influence specific cardiovascular diseases in particular geographical areas and patient subgroups.

Conclusions:

• The DD-ACE genotype appears to have a small, heterogeneous impact on specific cardiovascular diseases, influenced by geographical and patient-specific factors.
• Mechanisms of influence, including gene-gene interactions or biochemical pathways, remain largely unknown.
• The ACE enzyme is one component of the RAS cascade, suggesting a limited individual impact of a single genetic variant in complex multifactorial cardiovascular diseases.